{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:50:20Z","timestamp":1793429420431,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006190","name":"Veterans Affairs Office of Research & Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.psychres.2025.116359","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T19:27:49Z","timestamp":1736537269000},"page":"116359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A systematic review of participant diversity in psychedelic-assisted psychotherapy trials"],"prefix":"10.1016","volume":"345","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5486-1581","authenticated-orcid":false,"given":"Stephanie L.","family":"Haft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-7798","authenticated-orcid":false,"given":"Amanda E.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-8970","authenticated-orcid":false,"given":"Marissa","family":"Raymond-Flesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Fernandes-Osterhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6787-1490","authenticated-orcid":false,"given":"Ellen R.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"O'Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Woolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.psychres.2025.116359_bib0001","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00213-022-06123-7","article-title":"Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","volume":"239","author":"Aday","year":"2022","journal-title":"Psychopharmacology. (Berl)"},{"key":"10.1016\/j.psychres.2025.116359_bib0002","series-title":"2022 National Healthcare Quality and Disparities Report","year":"2022"},{"key":"10.1016\/j.psychres.2025.116359_bib0003","series-title":"APA Style Journal Article Reporting Standards","article-title":"Reporting standards for studies involving clinical trials","year":"2020"},{"key":"10.1016\/j.psychres.2025.116359_bib0004","unstructured":"American Psychological Association. (2021). APA Guidelines for Psychological Practice With Sexual Minority Persons."},{"key":"10.1016\/j.psychres.2025.116359_bib0005","series-title":"New Household Pulse Survey Data Reveals Differences Between LGBT and Non-LGBT Respondents During COVID-19 Pandemic","author":"Anderson","year":"2021"},{"key":"10.1016\/j.psychres.2025.116359_bib0006","first-page":"1","article-title":"Differences in psychological treatment outcomes by ethnicity and gender: an analysis of individual patient data","author":"Arundell","year":"2024","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"4","key":"10.1016\/j.psychres.2025.116359_bib0007","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00127-022-02378-9","article-title":"The association between social class and the impact of treatment for mental health problems: a systematic review and narrative synthesis","volume":"58","author":"Barnett","year":"2023","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2025.116359_bib0008","first-page":"23","article-title":"Why diverse representation in clinical research matters and the current state of representation within the clinical research ecosystem","author":"Bibbins-Domingo","year":"2022","journal-title":"Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups"},{"issue":"10","key":"10.1016\/j.psychres.2025.116359_bib80","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2025.116359_bib74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02791072.2008.10400637","article-title":"MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder","volume":"40","author":"Bouso","year":"2008","journal-title":"Journal of psychoactive drugs"},{"issue":"S1","key":"10.1016\/j.psychres.2025.116359_bib0009","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.2105\/AJPH.2010.300062","article-title":"Health disparities and health equity: the issue is justice","volume":"101","author":"Braveman","year":"2011","journal-title":"Am. J. Public Health"},{"issue":"5","key":"10.1016\/j.psychres.2025.116359_bib0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamapsychiatry.2022.0100","article-title":"Socioeconomic indicators of treatment prognosis for adults with depression: a systematic review and individual patient data meta-analysis","volume":"79","author":"Buckman","year":"2022","journal-title":"JAMa Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2025.116359_bib0011","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/eat.23699","article-title":"A systematic review of sociodemographic reporting and representation in eating disorder psychotherapy treatment trials in the United States","volume":"55","author":"Burnette","year":"2022","journal-title":"Int. J. Eating Dis."},{"key":"10.1016\/j.psychres.2025.116359_bib0012","series-title":"Best Practice Highlights: Lesbian, Gay, Bisexual, Transgender and People Who May Be Questioning Their Sexual Orientation Or Sexual Identity (LGBTQ)","author":"Cabaj","year":"2024"},{"issue":"15","key":"10.1016\/j.psychres.2025.116359_bib81","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.psychres.2025.116359_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjmad.2023.100023","article-title":"Perceptions of psychedelic-assisted therapy among Black Americans","volume":"4","author":"Carter","year":"2023","journal-title":"J. Mood. Anxiety Disord."},{"issue":"11","key":"10.1016\/j.psychres.2025.116359_bib75","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00213-018-5010-9","article-title":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study","volume":"235","author":"Danforth","year":"2018","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.psychres.2025.116359_bib82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA psychiatry"},{"issue":"10092","key":"10.1016\/j.psychres.2025.116359_bib0014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(16)31592-6","article-title":"Progress in evidence-based medicine: a quarter century on","volume":"390","author":"Djulbegovic","year":"2017","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.psychres.2025.116359_bib0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1037\/amp0000199","article-title":"Implications of research staff demographics for psychological science","volume":"73","author":"Does","year":"2018","journal-title":"American Psychol."},{"key":"10.1016\/j.psychres.2025.116359_bib0016","series-title":"Assessing the Feasibility of Asking About Sexual Orientation and Gender Identity in the Current Population survey: Results from Cognitive Interviews","author":"Ellis","year":"2017"},{"key":"10.1016\/j.psychres.2025.116359_bib0017","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00127-020-01918-5","article-title":"Social inequalities in antidepressant treatment outcomes: a systematic review","volume":"55","author":"Elwadhi","year":"2020","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"7","key":"10.1016\/j.psychres.2025.116359_bib0018","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMa"},{"key":"10.1016\/j.psychres.2025.116359_bib0064","series-title":"Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies Guidance for Industry","year":"2024"},{"issue":"4","key":"10.1016\/j.psychres.2025.116359_bib0019","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09540261.2018.1486289","article-title":"Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions","volume":"30","author":"Garcia-Romeu","year":"2018","journal-title":"Int. Rev. Psyc."},{"issue":"18","key":"10.1016\/j.psychres.2025.116359_bib83","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.psychres.2025.116359_bib84","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"Journal of psychopharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Archives of general psychiatry"},{"key":"10.1016\/j.psychres.2025.116359_bib0020","doi-asserted-by":"crossref","DOI":"10.1037\/cps0000059","article-title":"The inclusion of ethnoracial, sexual, and gender minority groups in randomized controlled trials of dialectical behavior therapy: a systematic review of the literature","author":"Harned","year":"2022","journal-title":"Clinic. Psychol. Sci. Practice"},{"issue":"12","key":"10.1016\/j.psychres.2025.116359_bib0021","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J. Psychopharmacology"},{"issue":"5","key":"10.1016\/j.psychres.2025.116359_bib0022","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/sltb.12637","article-title":"Variation in suicide risk among subgroups of sexual and gender minority college students","volume":"50","author":"Horwitz","year":"2020","journal-title":"Sui. Life-Threat. Beha."},{"key":"10.1016\/j.psychres.2025.116359_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102711","article-title":"Ethnoracial inclusion in clinical trials of psychedelics: a systematic review","volume":"74","author":"Hughes","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.psychres.2025.116359_bib0024","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib0026","doi-asserted-by":"crossref","first-page":"16976","DOI":"10.1038\/s41598-022-18645-3","article-title":"Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2025.116359_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jad.2024.10.058","article-title":"Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study","volume":"370","author":"Jones","year":"2025","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2025.116359_bib0027","doi-asserted-by":"crossref","first-page":"e34808","DOI":"10.2196\/34808","article-title":"Valuing diversity and inclusion in health care to equip the workforce: survey study and pathway analysis","volume":"6","author":"Khuntia","year":"2022","journal-title":"JMIR. Form. Res."},{"key":"10.1016\/j.psychres.2025.116359_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-018-0981-0","article-title":"Chromosomes to social contexts: sex and gender differences in PTSD","volume":"20","author":"Kimerling","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2025.116359_bib0029","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis","volume":"322","author":"Ko","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.psychres.2025.116359_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and mental health: a population study","volume":"8","author":"Krebs","year":"2013","journal-title":"PloS one"},{"issue":"6","key":"10.1016\/j.psychres.2025.116359_bib0030","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jcpt.13532","article-title":"US racial and ethnic participation in global clinical trials by therapeutic areas","volume":"46","author":"Lolic","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.psychres.2025.116359_bib0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pop.2021.02.007","article-title":"Sexual and gender minority health care disparities: barriers to care and strategies to bridge the gap","volume":"48","author":"Lund","year":"2021","journal-title":"Primary Care. Clini. Office Practice"},{"key":"10.1016\/j.psychres.2025.116359_bib0032","doi-asserted-by":"crossref","DOI":"10.1037\/cps0000067","article-title":"Reporting and inclusion of specific sociodemographic groups in the adult PTSD treatment outcome literature within the United States: A systematic review","author":"Madnick","year":"2022","journal-title":"Clinic. Psychol. Sci. Pract"},{"issue":"1688","key":"10.1016\/j.psychres.2025.116359_bib0033","article-title":"Perils and pitfalls of reporting sex differences","volume":"371","author":"Maney","year":"2016","journal-title":"Philosoph. Trans. Royal Soc. B. Biolog. Sci."},{"key":"10.1016\/j.psychres.2025.116359_bib0034","doi-asserted-by":"crossref","DOI":"10.1111\/sltb.13037","article-title":"Accounting for diversity in the treatment of suicide and self-injury: A systematic review of the past 50 years of randomized controlled trials","author":"Maria Guzm\u00e1n","year":"2024","journal-title":"Suic. Life-Threat. Behav"},{"key":"10.1016\/j.psychres.2025.116359_bib0035","series-title":"Social Determinants of Health","author":"Marmot","year":"2005"},{"issue":"2","key":"10.1016\/j.psychres.2025.116359_bib0036","first-page":"16","article-title":"MAPS doubles ethnoracial diversity in trials again: re-designing systems of care","volume":"32","author":"McKenna","year":"2022","journal-title":"MAPS Bulletin"},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-018-1824-6","article-title":"Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature","volume":"18","author":"Michaels","year":"2018","journal-title":"BMC. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2025.116359_bib0038","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.psychres.2025.116359_bib0039","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.psychres.2025.116359_bib77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of\u00b13, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"Journal of psychopharmacology"},{"issue":"6","key":"10.1016\/j.psychres.2025.116359_bib76","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3, 4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"The Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116359_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000217","article-title":"Guidance for developers of health research reporting guidelines","volume":"7","author":"Moher","year":"2010","journal-title":"PLoS. Med."},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib0041","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1176\/appi.focus.20190028","article-title":"Challenges and opportunities to meet the mental health needs of underserved and disenfranchised populations in the United States","volume":"18","author":"Mongelli","year":"2020","journal-title":"Focus. (Madison)"},{"issue":"11","key":"10.1016\/j.psychres.2025.116359_bib86","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"Journal of clinical Psychiatry"},{"key":"10.1016\/j.psychres.2025.116359_bib0042","series-title":"Measuring sex, Gender identity, and Sexual Orientation","author":"Medicine","year":"2022"},{"key":"10.1016\/j.psychres.2025.116359_bib0043","series-title":"Major Depression","year":"2023"},{"key":"10.1016\/j.psychres.2025.116359_bib0044","year":"2024","journal-title":"Diversity and Inclusion in Clinical Trials"},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (\u00b1 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"62","key":"10.1016\/j.psychres.2025.116359_bib0046","article-title":"Revisions to OMB's statistical policy directive no. 15: standards for maintaining, collecting, and presenting federal data on race and ethnicity","volume":"89","year":"2024","journal-title":"Fed. Regist."},{"issue":"7","key":"10.1016\/j.psychres.2025.116359_bib0047","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1176\/appi.ps.20220365","article-title":"Racial-ethnic disparities in outpatient mental health care in the United States","volume":"74","author":"Olfson","year":"2023","journal-title":"Psych. Servic."},{"key":"10.1016\/j.psychres.2025.116359_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2024.102446","article-title":"Sociodemographic representation in randomized controlled trials for anxiety-related disorders in the US: A systematic review (1993\u20132023)","author":"Ong","year":"2024","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.psychres.2025.116359_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109127","article-title":"Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations","volume":"214","author":"Ortiz","year":"2022","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.psychres.2025.116359_bib78","doi-asserted-by":"crossref","unstructured":"Ot\u2019alora G, M., Grigsby, J., Poulter, B., Van Derveer III, J. W., Giron, S. G., Jerome, L., ... & Doblin, R. (2018). 3, 4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. Journal of Psychopharmacology, 32(12), 1295-1307.","DOI":"10.1177\/0269881118806297"},{"key":"10.1016\/j.psychres.2025.116359_bib0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116359_bib0051","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cpr.2018.09.004","article-title":"Diversity in randomized clinical trials of depression: A 36-year review","volume":"67","author":"Polo","year":"2019","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.psychres.2025.116359_bib0052","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cpr.2018.09.004","article-title":"Diversity in randomized clinical trials of depression: A 36-year review","volume":"67","author":"Polo","year":"2019","journal-title":"Clin. Psychol. Rev."},{"issue":"9","key":"10.1016\/j.psychres.2025.116359_bib87","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.psychres.2025.116359_bib0053","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMa"},{"issue":"2","key":"10.1016\/j.psychres.2025.116359_bib0054","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.amepre.2021.07.012","article-title":"Suicidality among sexual minority adults: gender, age, and race\/ethnicity differences","volume":"62","author":"Ramchand","year":"2022","journal-title":"Am. J. Prev. Med."},{"issue":"3","key":"10.1016\/j.psychres.2025.116359_bib88","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med"},{"issue":"12","key":"10.1016\/j.psychres.2025.116359_bib89","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"Journal of psychopharmacology"},{"issue":"12","key":"10.1016\/j.psychres.2025.116359_bib0055","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.psychres.2025.116359_bib0056","first-page":"1013","article-title":"Measurement of socioeconomic status in health disparities research","volume":"99","author":"Shavers","year":"2007","journal-title":"J. Natl. Med. Assoc."},{"issue":"7","key":"10.1016\/j.psychres.2025.116359_bib90","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.psychres.2025.116359_bib0057","series-title":"Employment Rate in the United States from 1990 to 2023","year":"2024"},{"issue":"10","key":"10.1016\/j.psychres.2025.116359_bib0058","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/medethics-2021-107262","article-title":"Research abuses against people of colour and other vulnerable groups in early psychedelic research","volume":"48","author":"Strauss","year":"2022","journal-title":"J. Med. Ethics"},{"key":"10.1016\/j.psychres.2025.116359_bib0059","series-title":"R: A language and Environment For Statistical Computing","author":"Team","year":"2013"},{"key":"10.1016\/j.psychres.2025.116359_bib0063","series-title":"2015-2019 Drug Trials Snapshots Summary Report","year":"2020"},{"key":"10.1016\/j.psychres.2025.116359_bib0060","series-title":"QuickFacts United States","year":"2020"},{"key":"10.1016\/j.psychres.2025.116359_bib0061","series-title":"QuickFacts United States","year":"2020"},{"key":"10.1016\/j.psychres.2025.116359_bib0062","series-title":"Educational Attainment in the United States: 2021","year":"2022"},{"key":"10.1016\/j.psychres.2025.116359_bib0065","series-title":"Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials: Draft Guidance For Industry","year":"2022"},{"key":"10.1016\/j.psychres.2025.116359_bib0066","series-title":"Covidence Systematic Review Software","year":"2024"},{"key":"10.1016\/j.psychres.2025.116359_bib0068","doi-asserted-by":"crossref","DOI":"10.1177\/20503245231184638","article-title":"Minorities\u2019 diminished psychedelic returns","volume":"9","author":"Vi\u00f1a","year":"2023","journal-title":"Drug Sci. Policy. Law"},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib0067","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3102\/0091732X20903321","article-title":"How administrative data collection and analysis can better reflect racial and ethnic identities","volume":"44","author":"Viano","year":"2020","journal-title":"Review of Research in Education"},{"key":"10.1016\/j.psychres.2025.116359_bib91","doi-asserted-by":"crossref","unstructured":"von Rotz, R., Schindowski, E. M., Jungwirth, J., Schuldt, A., Rieser, N. M., Zahoranszky, K., ... & Vollenweider, F. X. (2023). Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. EClinicalMedicine, 56. Chicago.","DOI":"10.1016\/j.eclinm.2022.101809"},{"issue":"3","key":"10.1016\/j.psychres.2025.116359_bib0069","first-page":"279","article-title":"A systematic review of psychedelic-assisted psychotherapy for mental health: An evaluation of the current wave of research and suggestions for the future","volume":"7","author":"Wheeler","year":"2020","journal-title":"Psychol. Conscious. Theor. Rese. Pract."},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib0071","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1556\/2054.2019.016","article-title":"Culturally informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder","volume":"4","author":"Williams","year":"2020","journal-title":"J. Psychedelic. Stud."},{"key":"10.1016\/j.psychres.2025.116359_bib0070","first-page":"1","article-title":"Psychedelics and racial justice","author":"Williams","year":"2023","journal-title":"Int. J. Ment. Health Addict."},{"issue":"1","key":"10.1016\/j.psychres.2025.116359_bib79","doi-asserted-by":"crossref","first-page":"20442","DOI":"10.1038\/s41598-020-75706-1","article-title":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study","volume":"10","author":"Wolfson","year":"2020","journal-title":"Scientific reports"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:40:29Z","timestamp":1777336829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":90,"alternative-id":["S0165178125000083"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116359","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of participant diversity in psychedelic-assisted psychotherapy trials","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116359"}}